Morgan Stanley Lowers Gilead Sciences (NASDAQ:GILD) Price Target to $168.00

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price objective dropped by investment analysts at Morgan Stanley from $175.00 to $168.00 in a report issued on Friday,MarketScreener reports. Morgan Stanley’s target price suggests a potential upside of 27.92% from the company’s current price. Several other analysts have also recently issued reports on GILD. Sanford […]